Literature DB >> 16084011

Nek2 kinase in chromosome instability and cancer.

Daniel G Hayward1, Andrew M Fry.   

Abstract

Aneuploidy and chromosome instability are two of the most common abnormalities in cancer cells. They arise through defects in cell division and, specifically, in the unequal segregation of chromosomes between daughter cells during mitosis. A number of cell cycle dependent protein kinases have been identified that control mitotic progression and chromosome segregation. Some of these localize to the centrosome and regulate mitotic spindle formation. One such protein is Nek2, a member of the NIMA-related serine/threonine kinase family. Data are emerging that Nek2 is abnormally expressed in a wide variety of human cancers. In this review, we summarize current knowledge on the expression, regulation and function of Nek2, consider how Nek2 may contribute to chromosome instability, and ask whether it might make an attractive target for chemotherapeutic intervention in human cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084011     DOI: 10.1016/j.canlet.2005.06.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  72 in total

Review 1.  Therapeutic opportunities to control tumor cell cycles.

Authors:  Marcos Malumbres
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

2.  The Toxoplasma gondii centrosome is the platform for internal daughter budding as revealed by a Nek1 kinase mutant.

Authors:  Chun-Ti Chen; Marc-Jan Gubbels
Journal:  J Cell Sci       Date:  2013-05-31       Impact factor: 5.285

3.  Local depletion of DNA methylation identifies a repressive p53 regulatory region in the NEK2 promoter.

Authors:  Nancy H Nabilsi; Daniel J Ryder; Ashley C Peraza-Penton; Rosha Poudyal; David S Loose; Michael P Kladde
Journal:  J Biol Chem       Date:  2013-10-25       Impact factor: 5.157

4.  Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Authors:  Jia Wang; Peng Cheng; Marat S Pavlyukov; Hai Yu; Zhuo Zhang; Sung-Hak Kim; Mutsuko Minata; Ahmed Mohyeldin; Wanfu Xie; Dongquan Chen; Violaine Goidts; Brendan Frett; Wenhao Hu; Hongyu Li; Yong Jae Shin; Yeri Lee; Do-Hyun Nam; Harley I Kornblum; Maode Wang; Ichiro Nakano
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

5.  Meta-analysis of the expression of the mitosis-related gene Fam83D.

Authors:  Lokman Varisli
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

6.  NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Authors:  Wen Zhou; Ye Yang; Jiliang Xia; He Wang; Mohamed E Salama; Wei Xiong; Hongwei Xu; Shashirekha Shetty; Tiehua Chen; Zhaoyang Zeng; Lei Shi; Maurizio Zangari; Rodney Miles; David Bearss; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

7.  An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites.

Authors:  Luc Reininger; Rita Tewari; Clare Fennell; Zoe Holland; Dean Goldring; Lisa Ranford-Cartwright; Oliver Billker; Christian Doerig
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

Review 8.  Molecular mechanisms of microcystin toxicity in animal cells.

Authors:  Alexandre Campos; Vitor Vasconcelos
Journal:  Int J Mol Sci       Date:  2010-01-21       Impact factor: 6.208

9.  Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization.

Authors:  Daniel K Whelligan; Savade Solanki; Dawn Taylor; Douglas W Thomson; Kwai-Ming J Cheung; Kathy Boxall; Corine Mas-Droux; Caterina Barillari; Samantha Burns; Charles G Grummitt; Ian Collins; Rob L M van Montfort; G Wynne Aherne; Richard Bayliss; Swen Hoelder
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

10.  The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability.

Authors:  J Du; X Cai; J Yao; X Ding; Q Wu; S Pei; K Jiang; Y Zhang; W Wang; Y Shi; Y Lai; J Shen; M Teng; H Huang; Q Fei; E S Reddy; J Zhu; C Jin; X Yao
Journal:  Oncogene       Date:  2008-02-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.